Drugmaker Valeant completes $11 billion purchase of Salix

April 1, 2015 1:21 PM

3 0

April 1 (Reuters) - Canada's Valeant Pharmaceuticals International Inc completed its $10.96 billion purchase of Salix Pharmaceuticals Ltd, the acquisitive company said on Wednesday.

Salix, which specializes in gastrointestinal drugs such as , is Valeant's biggest purchase, and provides it with a new therapeutic business.

Read more

To category page